PROCEPT BioRobotics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$173.7M
Industry:Medical Equip
Founded:2009
Lead Investor(s):Viking Global Investors LP

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • PROCEPT BioRobotics's estimated annual revenue is currently $37.7M per year.
  • PROCEPT BioRobotics received $118.0M in venture funding in February 2018.
  • PROCEPT BioRobotics's estimated revenue per employee is $251,000
  • PROCEPT BioRobotics's total funding is $173.7M.

Employee Data

  • PROCEPT BioRobotics has 150 Employees.
  • PROCEPT BioRobotics grew their employee count by 9% last year.
  • PROCEPT BioRobotics currently has 16 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$41.7M166N/AN/A-N/A
#2
$30.4M12111%N/A-N/A
#3
$12M4845%N/A-N/A
#4
$18.8M75N/AN/A-N/A
#5
$26.9M1073%N/A5/5N/A
#6
$20.8M8328%N/A-N/A
#7
$26.1M104N/AN/A-N/A
#8
$25.4M101-6%N/A-N/A
#9
N/A4910N/AN/A-N/A
#10
$5.8M23N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

Based in Silicon Valley, PROCEPT BioRobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on benign prostatic hyperplasia (BPH), the company's first product, the AQUABEAM System delivering Aquablation therapy, is the world's first commercially available minimally invasive surgical robot providing autonomous tissue removal to safely and effectively treat BPH. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy or surgeon experience.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

150

Number of Employees

$37.7M

Revenue (est)

16

Current Jobs

9%

Employee Growth %

$173.7M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

PROCEPT BioRobotics News

13-Mar-19 - Six-Month Data Highlight Safety and Efficacy of PROCEPT

REDWOOD CITY, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics, a Silicon Valley surgical robotics company, announced today that

1-Oct-18 - Procept BioRobotics wins UK NICE nod, CMS NTAP approval

Procept BioRobotics said today that it won an Interventional Procedure Guidance recommendation from the UK's National Institute for Health

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$45.7M224N/AN/A4.5/5N/A
#2
$58M400N/AN/A4.4/5N/A
#3
$187.3M8927%N/A-N/A
#4
$2147.5M19933N/AN/A4/5N/A

PROCEPT BioRobotics Funding

DateAmountRoundLead InvestorsReference
2015-07-08$42.0MUndisclosedNovo A/SArticle
2015-07-21$7.7MUndisclosedArticle
2018-02-22$118.0MUndisclosedViking Global Investors LPArticle

PROCEPT BioRobotics Executive Hires

DateNameTitleReference
2018-11-08Kevin WatersCFOArticle